Inhibition of RIPK1 prevents keratinocyte cell death and reduces skin inflammation in type 1–mediated chronic inflammatory skin diseases

Journal:

The Journal of Allergy and Clinical Immunology

Published:

2026-02-17

DOI:

10.1016/j.jaci.2026.02.006

Affiliations:

7

Authors:

15

Go to article

Institutions	Authors	Share
Sanofi-Aventis Deutschland GmbH, Germany	4.500000	0.30
Technical University of Munich (TUM), Germany	3.500000	0.23
University Hospital of Munich (KUM), LMU, Germany	3.000000	0.20
Center of Allergy and Environment (ZAUM), Germany	1.833333	0.12
University Medical Center Freiburg, Germany	1.666667	0.11
Boehringer Ingelheim Vetmedica GmbH, Germany	0.500000	0.03

Interested in Clinical Sciences?